Page last updated: 2024-10-22

alfuzosin and Nycturia

alfuzosin has been researched along with Nycturia in 2 studies

alfuzosin: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'."7.74Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008)
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'."3.74Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leungwattanakij, S1
Watanachote, D1
Noppakulsatit, P1
Petchpaibuol, T1
Choeypunt, N1
Tongbai, T1
Wanamkang, T1
Lojanapiwat, B1
Permpongkosol, S1
Tantiwong, A1
Pripatnanont, C1
Akarasakul, D1
Kongwiwatanakul, S1
Chotikawanich, E1
Vallancien, G1
Emberton, M1
Alcaraz, A1
Matzkin, H1
van Moorselaar, RJ1
Hartung, R1
Harving, N1
Elhilali, M1

Trials

1 trial available for alfuzosin and Nycturia

ArticleYear
Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.
    The journal of sexual medicine, 2010, Volume: 7, Issue:9

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Erectile Dysfunction; Humans; Male; Midd

2010

Other Studies

1 other study available for alfuzosin and Nycturia

ArticleYear
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    BJU international, 2008, Volume: 101, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aged; Disease Progression; Erectile Dysfunction; Humans; Male; Nocturi

2008